Live 2021

Drug-resistant diseases could cause up to 10 million deaths a year by 2050, according to the World Health Organization. Scientists used the Canadian Light Source (CLS) at the University of Saskatchewan to better understand how current antibiotics work and how we might curb bacterial resistance to these life-saving drugs.
Read more ►

 


Live 2021

Researchers at The Ottawa Hospital and the University of Ottawa have been awarded more than $8 million to lead four national studies that will answer important questions about COVID-19 vaccines, including how well they work in people with cancer and immune conditions and in our aging population.
Read more ►

 


Live 2021

Published in Communications Biology, a new study by researchers from the Research Institute of the McGill University Health Centre (RI-MUHC) identified a protein that drives the development of a pancreatic cancer precursor lesion called acinar-to-ductal metaplasia (ADM).
Read more ►

 


Live 2021

“Technology and the Patient Consumer: Understanding Medical Choice and Care, 1900-2020” was the theme of a virtual workshop held jointly by the McGill Department of Social Studies of Medicine (SSOM) together with the Jewish General Hospital (JGH) on May 18-19.
Read more ►

 


Live 2021

In June 2021, Dr. Hellmuth (Ricky) Muller Moran completed his Master’s of Science in Experimental Surgery degree at McGill University, which included a research simulation fellowship at the Steinberg Centre for Simulation and Interactive Learning. During his studies, he worked with colleagues to develop a curriculum that would allow cardiac surgery residents to perform new transcatheter procedures as part of their residency training.
Read more ►

 


Live 2021

The Clinical Research Unit at The Neuro (CRU), a leading centre in ALS trials, recently partnered with the Weizmann Institute of Science in Israel to spearhead research into a potential new approach to treat ALS.  A clinical trial has recently launched at the CRU that will build on the pre-clinical research conducted in Prof. Eran Hornstein’s lab at the Weizmann Institute.
Read more ►

 


Live 2021

Screening is a major strategy in the global fight against cancer. Screening and its subsequent diagnostic and treatment services are proven to avert deaths from cancers of the uterine cervix, breast, colon/rectum, and lung. From the moment the World Health Organization declared that the initial outbreak of SARS-Cov-2 had attained pandemic status on March 11, 2020, attendance to health services became severely disrupted in many countries.
Read more ►

 


Live 2021

Lesch-Nyhan Disease is caused by the deficiency of a single enzyme which leads to excessive production of uric acid and severe movement problems. New research led by a team of McGill University scientists is shedding light on the dynamics involved in how this rare neurodevelopmental disease operates. Read more.
Read more ►

 


Live 2021

Today Genome Quebec announced the results of its Genomic Integration Program, Human Health Stream competition. Five McGill teams from a diverse array of fields were awarded funds, totaling nearly $1 million.
Read more ►

 


Live 2021

The past decade has seen tremendous strides made in cancer treatments. Increased access to clinical trials and personalized medicine have helped make many types of cancer treatable. According to the Canadian Cancer Society, the five-year survival for individuals diagnosed with a cancer is now 63%, meaning most Canadians have a better chance of surviving than ever before. But in the case of brain tumours, progress in developing new treatments has been slow.
Read more ►